Gradient Investments LLC Has $983,000 Stock Holdings in Aflac Incorporated (NYSE:AFL)

Gradient Investments LLC lowered its stake in Aflac Incorporated (NYSE:AFLGet Rating) by 2.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 13,663 shares of the financial services provider’s stock after selling 386 shares during the quarter. Gradient Investments LLC’s holdings in Aflac were worth $983,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in AFL. Truist Financial Corp boosted its position in shares of Aflac by 982.0% during the third quarter. Truist Financial Corp now owns 2,198,423 shares of the financial services provider’s stock worth $123,552,000 after purchasing an additional 1,995,240 shares in the last quarter. Invesco Ltd. increased its holdings in shares of Aflac by 62.4% in the first quarter. Invesco Ltd. now owns 4,936,608 shares of the financial services provider’s stock worth $317,865,000 after acquiring an additional 1,897,212 shares in the last quarter. Great West Life Assurance Co. Can acquired a new stake in shares of Aflac during the third quarter worth about $65,661,000. Envestnet Asset Management Inc. lifted its holdings in shares of Aflac by 225.2% during the 3rd quarter. Envestnet Asset Management Inc. now owns 1,076,386 shares of the financial services provider’s stock valued at $60,493,000 after purchasing an additional 745,346 shares in the last quarter. Finally, Maj Invest Holding A S grew its position in shares of Aflac by 16.5% in the 3rd quarter. Maj Invest Holding A S now owns 5,061,371 shares of the financial services provider’s stock valued at $325,902,000 after purchasing an additional 715,304 shares during the period. Institutional investors and hedge funds own 66.22% of the company’s stock.

Insider Transactions at Aflac

In other news, Director Joseph L. Moskowitz sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, January 3rd. The stock was sold at an average price of $71.98, for a total transaction of $35,990.00. Following the completion of the sale, the director now owns 19,751 shares in the company, valued at $1,421,676.98. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, Director Joseph L. Moskowitz sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, January 3rd. The stock was sold at an average price of $71.98, for a total transaction of $35,990.00. Following the completion of the sale, the director now owns 19,751 shares in the company, valued at $1,421,676.98. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Masatoshi Koide sold 19,291 shares of the business’s stock in a transaction that occurred on Tuesday, February 14th. The stock was sold at an average price of $70.36, for a total value of $1,357,314.76. Following the sale, the director now owns 87,598 shares of the company’s stock, valued at approximately $6,163,395.28. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on AFL shares. Morgan Stanley cut their price target on shares of Aflac from $78.00 to $77.00 and set an “overweight” rating on the stock in a research note on Friday, February 24th. Truist Financial increased their target price on Aflac from $65.00 to $70.00 and gave the stock a “hold” rating in a report on Monday, February 6th. JPMorgan Chase & Co. lifted their price target on Aflac from $62.00 to $66.00 and gave the company a “neutral” rating in a research note on Friday, January 6th. StockNews.com started coverage on Aflac in a research note on Thursday. They issued a “hold” rating on the stock. Finally, Raymond James lifted their price target on Aflac from $74.00 to $77.00 and gave the company an “outperform” rating in a research note on Monday, January 30th. Six investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $71.75.

Aflac Price Performance

Shares of NYSE AFL opened at $61.29 on Friday. The stock has a market capitalization of $37.52 billion, a price-to-earnings ratio of 9.33, a PEG ratio of 2.19 and a beta of 0.94. The business has a 50-day moving average of $69.23 and a 200-day moving average of $66.77. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.06 and a quick ratio of 0.06. Aflac Incorporated has a fifty-two week low of $52.07 and a fifty-two week high of $74.01.

Aflac (NYSE:AFLGet Rating) last announced its quarterly earnings data on Thursday, February 2nd. The financial services provider reported $1.29 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.08. The company had revenue of $4.01 billion during the quarter, compared to analysts’ expectations of $4.49 billion. Aflac had a return on equity of 13.69% and a net margin of 21.54%. Aflac’s revenue for the quarter was down 26.2% compared to the same quarter last year. During the same quarter last year, the company earned $1.28 EPS. As a group, sell-side analysts predict that Aflac Incorporated will post 5.59 earnings per share for the current fiscal year.

Aflac Company Profile

(Get Rating)

Aflac, Inc is a holding company. engages in the provision of financial protection services. It operates through the followings segments: Aflac Japan and Aflac United States (U.S.). The Aflac Japan segment offers life insurance, death benefits, and cash surrender values. The Aflac U.S. segment sells voluntary supplemental insurance products for people who already have major medical or primary insurance coverage.

See Also

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.